Pharmacielo Ltd faces ongoing challenges in the healthcare sector, which is affecting its market performance.
Pharmacielo Ltd (PCLO.V) has experienced a notable decline in its stock price over the past week, dropping 8.33%. As of today, the stock closed at C$0.06, unchanged from the previous day. Year-to-date, the company’s performance is concerning, with a decline of 59.26%. In this report, we will explore the technical picture and key metrics surrounding Pharmacielo Ltd.
Investor takeaway: Investors should be aware of the significant volatility surrounding Pharmacielo Ltd, especially given its low trading volume and challenging financial fundamentals. The stock's performance may be influenced by broader trends in the healthcare sector.
Advertisement
Pharmacielo Ltd
PCLO.V
PCLO.V
Pharmacielo Ltd
WealthAwesomeMarket cap
$12.16M
52W high
$0.17
52W low
$0.04
1W change
-8.33%
Beta
0.54
Analyst Price Targets
Based on analyst covering PCLO · as of Sep 17, 2026
Wall Street analysts forecast PCLO stock price to rise 4445.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.50
+4445.5% Upside
Current Price
C$0.06
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PCLO's historical volatility
30-Day Vol
163.6%
Annualized
90-Day Vol
183.1%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.05
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.05 | C$0.03 – C$0.09 |
| 60 trading days | C$0.05 | C$0.02 – C$0.11 |
| 90 trading days | C$0.05 | C$0.02 – C$0.12 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Pharmacielo Ltd's stock has dropped 59.26% year-to-date.
The stock has a beta of 0.54, indicating lower volatility compared to the broader market, but this does not lessen the risks associated with its poor financial performance.
Bull case
Analysts remain optimistic, with an average target price of C$2.50. This suggests a significant upside potential if the company can improve its financial situation.
Bear case
Pharmacielo Ltd's financial health raises concerns for potential investors, with a profit margin of -103.1% and a return on equity (ROE) of -3013.2%.
Recent Price Action
Pharmacielo Ltd's stock closed at C$0.06 on Tuesday, unchanged from the previous day. Over the past week, the stock has decreased by 8.33%, reflecting ongoing challenges for the company. Year-to-date, Pharmacielo Ltd has seen a staggering decline of 59.26%, raising concerns among investors about its future prospects.
Technical Picture
Advertisement
The technical indicators for Pharmacielo Ltd present a cautionary outlook. The stock is currently trading below both its 50-day moving average of C$0.06 and its 200-day moving average of C$0.07, indicating a bearish trend. The 52-week range for the stock is C$0.04 to C$0.17, with the current price situated at approximately 15% of this range. The stock's beta of 0.54 suggests lower volatility compared to the broader market, but the recent trading volume of 29,200 shares is significantly below the 20-day average volume of 73,344 shares, indicating reduced investor interest.
Insider Activity
There is no recent insider activity reported for Pharmacielo Ltd, which could indicate a lack of confidence from insiders in the company's prospects.
Market Outlook
Despite the current challenges, analysts maintain a bullish outlook for Pharmacielo Ltd, with an average target price of C$2.50. This implies a potential upside of over 4445.5% from the current trading price. However, potential investors should weigh this optimistic view against the company's significant financial struggles, including a profit margin of -103.1% and a return on equity (ROE) of -3013.2%.
Conclusion
Pharmacielo Ltd's stock performance remains under pressure, with significant declines over the past week and year-to-date. Investors should consider the company's technical indicators and financial health before making any decisions. As it stands, the stock closed at C$0.06, unchanged for the day.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
